InvestorsHub Logo
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

Re: XenaLives post# 85484

Friday, 12/23/2016 1:40:28 PM

Friday, December 23, 2016 1:40:28 PM

Post# of 465858
273+Aducanumab would not have the problems that 273+dzp has. They don't interfere with each other biochemically. Whereas, DZP crowds out 273 from the sigma 1 receptor sites and negatively affects 273's activity on the muscarinic receptors. Biochemically speaking, it should be a hindrance to 273.

If 273 ever stops working for a patient, then taking them off 273 and putting them on DZP would be an option.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News